申请人:Nektar Therapeutics
公开号:US10189859B2
公开(公告)日:2019-01-29
The instant disclosure relates to (among other things) compounds that are derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine. The compounds provided possess unique effects and differences over other phenyltriazines known in the art.
本公开涉及 6-(2,3-二氯苯基)-1,2,4-三嗪-5-胺衍生物的化合物。与本领域已知的其他苯基三嗪相比,所提供的化合物具有独特的效果和差异。